News

Lenacapavir could be a gamechanger in the fight against infection. But US funding cuts have thrown the rollout of the ...
A trial of the influenza antiviral baloxavir suggests that the drug could be used as post-exposure prophylaxis to prevent ...
Gilead Sciences on Thursday reported a first-quarter profit, but revenue was flat, as higher sales of drugs for HIV and liver ...
As external funding dwindles, the Federal Government has called for state governments’ involvement in the domestic ownership ...
The cancellation of PEPFAR funding to South Africa could cause between 150,000 and 295,000 additional HIV infections by the ...
Four out of 10 survivors of sexual and gender-based violence experience delays in accessing life-saving services such as emergency contraception, post-exposure prophylaxis for HIV, treatment for ...
Data from the last five years show that many people who contracted HIV had seen a provider in the year before.
Explore 7 leading HIV care centers in Philadelphia for 2025, offering compassionate, comprehensive services for all.